Exact Mass: 706.1969724
Exact Mass Matches: 706.1969724
Found 53 metabolites which its exact mass value is equals to given mass value 706.1969724
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Phenyl-agarose
Epicatechin-(2alpha->7,4alpha->8)-epicatechin 3-galactoside
Epicatechin-(2alpha->7,4alpha->8)-epicatechin 3-galactoside is a member of the class of compounds known as biflavonoids and polyflavonoids. Biflavonoids and polyflavonoids are organic compounds containing at least two flavan/flavone units. These units are usually linked through CC or C-O-C bonds. Some examples include C2-O-C3, C2-O-C4, C3-C3, and C6-C8. Epicatechin-(2alpha->7,4alpha->8)-epicatechin 3-galactoside is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Epicatechin-(2alpha->7,4alpha->8)-epicatechin 3-galactoside can be found in chocolate and cocoa powder, which makes epicatechin-(2alpha->7,4alpha->8)-epicatechin 3-galactoside a potential biomarker for the consumption of these food products.
6)-glucoside]
subulatin
An alkyl caffeate ester isolated from Lophocolea heterophylla and Jungermannia subulata and has been shown to exhibit antioxidant activity.
Kaempferol 3-[2,3,4-triacetyl-alpha-L-arabinopyranosyl-(1->6)-glucoside]
Kaempferol 3-[2,3,5-triacetyl-alpha-L-arabinofuranosyl-(1->6)-glucoside
rel-(1S,2R,3R,5S,7R)-7-[(E)-caffeoyloxymethyl]-2,3-di[(E)-caffeoyloxy]-6,8-dioxabicyclo[3.2.1]octane-5-carboxylic acid
ent-epiafzelechin-(2alpha?O?7,4alpha?8)-ent-afzelechin 3?-O-beta-D-glucopyranoside
3-O-p-coumaroyl-6-O-feruloyl-beta-D-fructofuranosyl 6-O-acetyl-alpha-D-glucopyranoside
beta-D-(2-phenylglucopyranosyl)-(6->1)-(2,4-diphenylrhamnopyranosyl)-3,4,5-trihydroxybenzoate
[(2S,3S,4R,5R,6R)-5-acetyloxy-3-hydroxy-2-methyl-6-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[5-hydroxy-6-methoxy-2-(4-methoxyphenyl)-4-oxochromen-7-yl]oxyoxan-2-yl]methoxy]oxan-4-yl] acetate
W-84 dibromide
W-84 (dibromide) is a potent allosteric modulator of M2-cholinoceptors, which retards [3H]N-methylscopolamine dissociation. W-84 dibromide can stabilize cholinergic antagonist-receptor complexes. W-84 (dibromide) is a non-competitive muscarinic acetylcholine receptors antagonist with allosteric effects. W-84 (dibromide) protects over additively against an organophosphate-intoxication when applied in combination with atropine[1][2][3].
BIS(DI-TERT-BUTYL(4-DIMETHYLAMINOPHENYL)PHOSPHINE)DICHLOROPALLADIUM(II)
Cyclo(-Arg-Ala-Asp-D-Phe-Cys) trifluoroacetate salt
C27H37F3N8O9S (706.2356188000001)
6-Oxa-4,11,16,23-tetraaza-5-phosphatetracosane-1,3,10,15-tetracarboxylic acid, 24-(4-fluorophenyl)-5-hydroxy-12,17,24-trioxo-, 5-oxide, (3S,10S,15S)-
2-[[3-[2-[(3,4-Dihydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl)oxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-6-(hydroxymethyl)-2-phenyloxane-3,4,5-triol
(-)-Epicatechin-(2a-7)(4a-8)-epicatechin 3-O-galactoside
7-(4-hydroxy-3,5-dimethoxyphenyl)-11-oxo-6-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxymethyl]oxan-2-yl]oxy-2,8-dioxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,9-pentaene-3-carboxylic acid
3,4,5-trihydroxy-6-[[3-hydroxy-2-(3-hydroxyphenyl)-4-[3,5,7-trihydroxy-2-(3-hydroxyphenyl)-3,4-dihydro-2H-chromen-8-yl]-3,4-dihydro-2H-chromen-7-yl]oxy]oxane-2-carboxylic acid
4,10,14-trihydroxy-5-[(1s,9s)-5-hydroxy-9-methyl-8-oxatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraen-11-yl]-1-(3-methylbut-2-en-1-yl)-2-oxo-9,17-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-3,5,7,11,13,15-hexaen-6-yl 2,4-dihydroxybenzoate
2-[(3-{[4-(acetyloxy)-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-hydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl)oxy]-4,5-dihydroxy-6-methyloxan-3-yl 2-methylpropanoate
3-o-p-coumaroyl-6-o-feruloyl-β-d-fructo-furanosyl 6-o-acetyl-α-d-glucopyranoside
{"Ingredient_id": "HBIN009373","Ingredient_name": "3-o-p-coumaroyl-6-o-feruloyl-\u03b2-d-fructo-furanosyl 6-o-acetyl-\u03b1-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C33H38O17","Ingredient_Smile": "CC(=O)OCC1C(C(C(C(O1)OC2(C(C(C(O2)COC(=O)C=CC3=CC(=C(C=C3)O)OC)O)OC(=O)C=CC4=CC=C(C=C4)O)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4157","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(2s,3s,4s,5r,6s)-6-{4-[(r)-[(3s)-3-[(2-{4-[(3r)-3-amino-3-carboxypropoxy]phenyl}-1,2-dihydroxyethylidene)amino]-3-[(hydroxymethylidene)amino]-2-oxoazetidin-1-yl](carboxy)methyl]phenoxy}-3,4,5-trihydroxyoxane-2-carboxylic acid
(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-({[(2r,3r,4s,5s,6s)-4-hydroxy-6-methyl-3,5-diphenoxyoxan-2-yl]oxy}methyl)-3-phenoxyoxan-2-yl 3,4,5-trihydroxybenzoate
(3r,4ar,12bs)-4a,8,12b-trihydroxy-9-[(2s,4s,5r,6s)-4-hydroxy-6-methyl-5-[(6-methyl-5-oxo-2,6-dihydropyran-2-yl)oxy]oxan-2-yl]-3-methyl-3-[(6-methyl-5-oxo-2,6-dihydropyran-2-yl)oxy]-2,4-dihydrotetraphene-1,7,12-trione
(2s,3r,4r,5r,6s)-2-[(3-{[(2s,3r,4s,5r,6r)-4-(acetyloxy)-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-hydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl)oxy]-4,5-dihydroxy-6-methyloxan-3-yl 2-methylpropanoate
6-(4-{[3-({2-[4-(3-amino-3-carboxypropoxy)phenyl]-1,2-dihydroxyethylidene}amino)-3-[(hydroxymethylidene)amino]-2-oxoazetidin-1-yl](carboxy)methyl}phenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
(3r,4ar,12bs)-9-[(1s,10s,12s,14s)-5,14-dimethyl-6-oxo-2,4,9,13-tetraoxatricyclo[8.4.0.0³,⁸]tetradecan-12-yl]-4a,8,12b-trihydroxy-3-methyl-3-[(6-methyl-5-oxo-2,6-dihydropyran-2-yl)oxy]-2,4-dihydrotetraphene-1,7,12-trione
4,5-dihydroxy-6-{[(4-hydroxy-6-methyl-3,5-diphenoxyoxan-2-yl)oxy]methyl}-3-phenoxyoxan-2-yl 3,4,5-trihydroxybenzoate
[(2r,3r,4s,5s)-5-{[(2r,3r,4s,5s,6r)-6-[(acetyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl]oxy}-3-hydroxy-5-(hydroxymethyl)-4-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}oxolan-2-yl]methyl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
[(2r,3s,4r,5r)-3,4-bis(acetyloxy)-5-{[(2s,3s,4r,5s,6s)-6-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methoxy}oxolan-2-yl]methyl acetate
(1s,10s)-4,10,14-trihydroxy-5-[(1r,9s)-5-hydroxy-9-methyl-8-oxatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraen-11-yl]-1-(3-methylbut-2-en-1-yl)-2-oxo-9,17-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-3,5,7,11,13,15-hexaen-6-yl 2,4-dihydroxybenzoate
(3s,5as,6s,10ar)-3-{[(3s,5as,6s,10ar)-6-(acetyloxy)-3-hydroxy-3-(hydroxymethyl)-2-methyl-1,4-dioxo-5ah,6h,10h-pyrazino[1,2-a]indol-10a-yl]disulfanyl}-10a-hydroxy-3-(hydroxymethyl)-2-methyl-1,4-dioxo-5ah,6h,10h-pyrazino[1,2-a]indol-6-yl acetate
C30H34N4O12S2 (706.1614564000001)